Ensign Peak Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Sell |
|
|||||
|
2025
Q1 | $14M | Buy |
|
|||||
|
2024
Q4 | $9.4M | Hold |
|
|||||
|
2024
Q3 | $7.73M | Hold |
|
|||||
|
2024
Q2 | $6.37M | Buy |
|
|||||
|
2024
Q1 | $807K | Sell |
|
|||||
|
2023
Q4 | $803K | Hold |
|
|||||
|
2023
Q3 | $653K | Hold |
|
|||||
|
2023
Q2 | $1.19M | Hold |
|
|||||
|
2023
Q1 | $1.41M | Sell |
|
|||||
|
2022
Q4 | $7.11M | Buy |
|
|||||
|
2022
Q3 | $865K | Buy |
|
|||||
|
2022
Q2 | $633K | Buy |
|
|||||
|
2022
Q1 | $430K | Buy |
|
|||||
|
2021
Q4 | $398K | Buy |
|
|||||
|
2021
Q3 | $243K | Sell |
|
|||||
|
2021
Q2 | $785K | Hold |
|
|||||
|
2021
Q1 | $879K | Sell |
|
|||||
|
2020
Q4 | $3.38M | Buy |
|
|||||
|
2020
Q3 | $1.36M | Buy |
|
|||||
|
2020
Q2 | $334K | Hold |
|
|||||
|
2020
Q1 | $293K | Sell |
|
|||||
|
2019
Q4 | $806K | Buy |
|